Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoximone and Esmolol in High-Risk Vascular Surgery
NCT00348101Phase 3Completed
- Sponsor
- Klinikum Ludwigshafen
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary artery disease (CAD) comparing Enoximone + Esmolol with Placebo + Esmolol (2 arms). Primary endpoint: Brain Natriuretic Peptide. Started Jun 2006; status: completed.
02
Drugs
enoximone
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00348101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348101.